Background: Cerebrovascular accident (CVA) is a major global contributor to death and disability. As part of its medical management, researchers have recognized the importance of promising neuroprotective strategies, where stem cell transplantation (SCT) is thought to confer advantages trophic and neuroprotective effects.
Aim: To evaluate the current state of research on SCT in patients with CVA, assess key trends and highlight literature gaps.